Provided by Tiger Trade Technology Pte. Ltd.

Revive Therapeutics Ltd.

0.0087
+0.00022.82%
Volume:193.28K
Turnover:1.70K
Market Cap:3.66M
PE:-1.31
High:0.0088
Open:0.0088
Low:0.0070
Close:0.0085
52wk High:0.0250
52wk Low:0.0051
Shares:418.56M
Float Shares:411.61M
Volume Ratio:0.67
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0066
EPS(LYR):-0.0108
ROE:-664.21%
ROA:-16.11%
PB:-1.43
PE(LYR):-0.81

Loading ...

Company Profile

Company Name:
Revive Therapeutics Ltd.
Exchange:
PINK LIMITED
Establishment Date:
- -
Employees:
2
Office Location:
The Canadian Venture Building,82 Richmond Street East,Toronto,Ontario,Canada
Zip Code:
M5C 1P1
Fax:
905-248-3355
Introduction:
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.